Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

In June, Esperion Therapeutics Inc. (NASDAQ:ESPR), an Ann Arbor-based early-stage pharmaceutical company, raised $73 million in its IPO. It plans a secondary offering this year, based on trial results of its cholesterol-lowering drug. Esperion Therapeutics Inc (NASDAQ:ESPR) stock performance was -5.04% in last session and finished the day at $14.69. Traded volume was 31,400 shares in the last session and the average volume of the … Continue reading Losers to Watch: Esperion Therapeutics Inc (NASDAQ:ESPR), Egalet Corp (NASDAQ:EGLT), Ocera Therapeutics (NASDAQ:OCRX), La Jolla Pharmaceutical (NASDAQ:LJPC), Omeros (NASDAQ:OMER)

John Bellich08/1408/14

Top Losers: Potbelly (NASDAQ:PBPB), Net Element International (NASDAQ:NETE), Lumber Liquidators (NYSE:LL), Ocera Therapeutics Inc (NASDAQ:OCRX)

Potbelly Corp. (NASDAQ:PBPB), the hot-sandwich seller that went public nine months ago, dropped the most since its October initial public offering after its annual profit forecast and quarterly sales trailed analysts’ estimates. Potbelly Corp (NASDAQ:PBPB) stock performance was -25.12% in last session and finished the day at $10.97. Traded volume was 7.27million shares in the last session and the average volume of the stock remained … Continue reading Top Losers: Potbelly (NASDAQ:PBPB), Net Element International (NASDAQ:NETE), Lumber Liquidators (NYSE:LL), Ocera Therapeutics Inc (NASDAQ:OCRX)

John Bellich07/11